Chondrosarcoma

Common Name(s)

Chondrosarcoma

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Chondrosarcoma" for support, advocacy or research.

Logo
Sarcoma Alliance

The Sarcoma Alliance strives to improve the lives of people affected by sarcoma through accurate diagnosis, improved access to care, guidance, education and support.

Last Updated: 20 Feb 2013

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Chondrosarcoma" for support, advocacy or research.

Logo
Sarcoma Alliance

The Sarcoma Alliance strives to improve the lives of people affected by sarcoma through accurate diagnosis, improved access to care, guidance, education and support.

http://sarcomaalliance.org

Last Updated: 20 Feb 2013

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Chondrosarcoma" returned 429 free, full-text research articles on human participants. First 3 results:

Diacerein retards cell growth of chondrosarcoma cells at the G2/M cell cycle checkpoint via cyclin B1/CDK1 and CDK2 downregulation.
 

Author(s): Birgit Lohberger, Andreas Leithner, Nicole Stuendl, Heike Kaltenegger, Werner Kullich, Bibiane Steinecker-Frohnwieser

Journal:

 

Chondrosarcoma is characterized for its lack of response to conventional cytotoxic chemotherapy, propensity for developing lung metastases, and low rates of survival. Research within the field of development and expansion of new treatment options for unresectable or metastatic diseases ...

Last Updated: 11 Nov 2015

Go To URL
Epidemiological Aspects of Osteosarcoma, Giant Cell Tumor and Chondrosarcoma Musculoskeletal Tumors--Experience of the National Rehabilitation Institute, Mexico City.
 

Author(s): P DelaGarza-Montano, E Estrada-Villasenor, R Dominguez Rubio, V Martinez-Lopez, A Avila-Luna, A Alfaro-Rodriguez, D Garciadiego-Cazares, A Carlos, A D Hernandez-Perez, C Bandala

Journal: Asian Pac. J. Cancer Prev.. 2015 ;16(15):6451-5.

 

Primary bone neoplasms are rare, contributing only 0.2% of the global burden of all human malignancies. Osteosarcoma (OS) and chondrosarcoma (CS) are the most common malignancies of bone. The giant cell tumor of bone (GCTb) is a benign tumor with behavior characterized by osteolytic ...

Last Updated: 5 Oct 2015

Go To URL
Chondrosarcoma of the hyoid bone: a case report.
 

Author(s): Mircea Sorin Ciolofan, Elena Ioniţă, Iulică Ioniţă, Carmen Aurelia Mogoantă, Florin Anghelina, Anca Ştefania Enescu, Diana Maria Ciobîrcă, Andrei Osman, Maria Camelia Foarfă, Garofiţa Olivia Mateescu

Journal: Rom J Morphol Embryol. 2015 ;56(2 Suppl):811-6.

 

Chondrosarcoma is a malignancy of the mesenchymal tissue derived from transformed cells that produce the cartilage matrix. In the neck area, it represents less than 0.5% of malignant tumor pathology. Chondrosarcoma of the hyoid bone is extremely rare, only 20 cases having been published ...

Last Updated: 2 Oct 2015

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Chondrosarcoma" returned 45 free, full-text review articles on human participants. First 3 results:

Paravertebral extraskeletal myxoid chondrosarcoma: a case report and review of the literature.
 

Author(s): Fatima Zahra Farhane, Zineb Alami, Touria Bouhafa, Abderrahmane Elmazghi, Khalid Hassouni

Journal:

 

The extraskeletal myxoid chondrosarcoma (CME) is a rare malignant soft tissue tumour described as a distinct clinical, histological, immunohistochemical, genetical and evolutive entity. It represents only 2.5% of soft tissue sarcomas. Its individualization is important because it ...

Last Updated: 9 Oct 2015

Go To URL
[Extra-skeletal myxoid chondrosarcoma: report of a case and review of literature].
 

Author(s): Youness Sasbou, Abdelkarim Rhanim, Younes Mhammdi, Mustapha Nkaoui, Ahmed El Bardouni, Mohammed Saleh Berrada, Morad El Yaacoubi

Journal:

 

Last Updated: 18 Jul 2015

Go To URL
Chondrosarcoma of the larynx: report of two cases and review of the literature.
 

Author(s): Qinying Wang, Haihong Chen, Shuihong Zhou

Journal:

 

Primary chondroid tumors of the larynx represent less than 1% of all laryngeal tumors. Most of them are chondromas and they often involve to the cricoid cartilage. They are characterized by a low tendency to metastatic diffusion (low grade). The treatment of choice is surgery, which ...

Last Updated: 14 May 2015

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma
 

Status: Recruiting

Condition Summary: Conventional Chondrosarcoma; Myxoid Liposarcoma; Mesenchymal Chondrosarcoma; Dedifferentiated Chondrosarcoma

 

Last Updated: 11 Jul 2016

Go to URL
A Phase II Study of EVEROLIMUS in Patients With Primary or Relapsed Chondrosarcomas
 

Status: Recruiting

Condition Summary: Chondrosarcoma

 

Last Updated: 11 May 2016

Go to URL